Catalyst Event
Medtronic PLC (MDT) · Other
From Akros SCHK HK-Global Brain-Computer Interface Index (ASHGBCI)
3/24/2026, 12:00:00 AM
On March 24, 2026, Medtronic announced an exclusive distribution agreement with Merit Medical Systems to offer the ViaVerte basivertebral nerve ablation (BVNA) system for treating chronic lower-back pain. (Estimated 1% impact due to new distribution channel).
Korean Translation
2026년 3월 24일, 메드트로닉은 만성 요통 치료를 위한 '비아베르테(ViaVerte)' 기저척추신경절제술(BVNA) 시스템을 공급하기 위해 메리트 메디컬 시스템즈(Merit Medical Systems)와 독점 유통 계약을 체결했다고 발표함. (신규 유통 채널 확보로 인해 1% 내외의 주가 영향이 예상됨).
Related Recent Events
Eli Lilly and Co (LLY) · Earnings Release
First quarter 2026 earnings release and conference call, which is estimated to have a >=10% price impact, is scheduled.
4/30/2026, 12:00:00 AM
Abbott Laboratories (ABT) · Earnings Release
Abbott's first-quarter 2026 financial results announcement and conference call on April 16, 2026, for which market analysts estimate a >=5% price impact, are scheduled.
4/16/2026, 12:00:00 AM
Johnson & Johnson (JNJ) · Earnings Release
Johnson & Johnson's Q1 2026 earnings release is scheduled for April 14, 2026, before the market opens scheduled.
4/14/2026, 12:00:00 AM
Eli Lilly and Co (LLY) · Other
U.S. Food and Drug Administration (FDA) decision on orforglipron, an oral weight-loss pill, is expected. The target action date was previously extended, and a >=10% price impact is expected.
4/10/2026, 12:00:00 AM
Oracle Corp (ORCL) · Other
Veritone announced on March 26, 2026, a multi-year agreement to migrate its AI solutions to Oracle Cloud Infrastructure (OCI), signaling a strategic customer win for Oracle's cloud business.
3/26/2026, 12:00:00 AM
Abbott Laboratories (ABT) · Other
S&P Global Ratings is expected to downgrade Abbott's credit rating to 'A+' from 'AA-' on March 24, 2026, following the Exact Sciences acquisition; market analysts estimate a >=10% price impact.
3/24/2026, 12:00:00 AM